Search Results for

Showing 1 - 3 of 3 results
  1. Trending topics: Patient engagement

    Trending topics Patients: From consumers to partners Passenger. End user. Spectator. These are terms that many in biomedical research would use to describe the role patients play as a potential therapy winds its way along the development pipeline. Yet, a growing number of patients are no longer content to simply watch and wait as possible life-changing science happens without them.  “Other than providing funding, the patient community hasn’t traditionally been given the opportunity to intera

  2. Spotlight on members: Spark

    Spotlight on members From hospital funding to FDA approval Spark Therapeutics develops gene therapy for inherited retinal blindness After over two decades of research and development in gene therapy, Katherine A. High, MD, co-founder, president and chief scientific officer of Spark Therapeutics, is breathing a big sigh of relief this fall. On Oct. 12, the Food and Drug Administration unanimously voted to approve voretigene neparvovec, Spark Therapeutics' gene therapy treatment for inherited b

  3. Spotlight on members: Beckman-Argyros awardee

    Spotlight on members Extending OCT from structure to function  Beckman-Argyros Award furthers research of James Fujimoto Scientists are all too aware of the gap between high risk, high impact ideas and the funding necessary to pursue them. Fortunately, so is the Arnold and Mabel Beckman Foundation. Through its Beckman-Argyros Award in Vision Research, the Foundation funds potentially high-impact work that lacks the full suite of data necessary to secure government funding. Through this year’s